The promotion of IFN-γ and TNF-α secretion in co-culture experiments of tumor cells and T cells using cyclic peptides also validates the potential of degradation agents as an effective approach to address practical issues in tumor immunotherapy, such as the low effectiveness of PD-1/PD-L1 antagonists in tumor treatment. The gene discussed is IFNG; the disease is neoplasm.